Neto Malinda Trading Ltd. (TLV:NTML)
Israel · Delayed Price · Currency is ILS · Price in ILA 14,220
-10 (-0.07%)
Jul 31, 2025, 5:24 PM IDT
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 227.7 | 204.15 | 88.28 | 127.82 | 191.8 | 146.21 | Upgrade |
Depreciation & Amortization | 49.99 | 49.72 | 44.84 | 38.11 | 35.15 | 33.86 | Upgrade |
Loss (Gain) From Sale of Assets | -0.56 | -0.54 | -0.95 | -0.95 | -0.66 | -0.64 | Upgrade |
Loss (Gain) on Equity Investments | -2.42 | -2.72 | -1.7 | -1.69 | -1.23 | -0.04 | Upgrade |
Other Operating Activities | 26.7 | 52.64 | -23.79 | -47.14 | 21.11 | 23.94 | Upgrade |
Change in Accounts Receivable | -127.53 | -117.47 | 59.07 | -90.11 | -130.49 | -42.06 | Upgrade |
Change in Inventory | -101.32 | -29.04 | -12.94 | -28.71 | -18.15 | -63.93 | Upgrade |
Change in Accounts Payable | 111.02 | 164.27 | 57.18 | -74.8 | -15.3 | 32.54 | Upgrade |
Change in Other Net Operating Assets | 4.14 | 3.25 | 3 | 3.06 | 3.33 | 2.93 | Upgrade |
Operating Cash Flow | 187.71 | 324.26 | 213.02 | -74.39 | 85.57 | 132.81 | Upgrade |
Operating Cash Flow Growth | -7.86% | 52.23% | - | - | -35.57% | 53.22% | Upgrade |
Capital Expenditures | -41.39 | -41.49 | -67.03 | -43.05 | -19.98 | -16.06 | Upgrade |
Sale of Property, Plant & Equipment | 3.49 | 3.51 | 3.47 | 2.27 | 2.04 | 3.51 | Upgrade |
Cash Acquisitions | - | - | - | -29.17 | -32.76 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.18 | -0.17 | -0.43 | -0.34 | - | - | Upgrade |
Sale (Purchase) of Real Estate | 1.34 | 1.34 | - | - | - | - | Upgrade |
Investment in Securities | 0.15 | 0.03 | -9.11 | 0.46 | 3.5 | 1.06 | Upgrade |
Other Investing Activities | -0.1 | -0.09 | - | - | 8.33 | 7.11 | Upgrade |
Investing Cash Flow | -16.69 | -34.86 | -71.1 | -65.83 | 42.05 | -69.28 | Upgrade |
Short-Term Debt Issued | - | - | - | 144.62 | - | 48.17 | Upgrade |
Total Debt Issued | 115.39 | - | - | 144.62 | - | 48.17 | Upgrade |
Short-Term Debt Repaid | - | -197.56 | -133.5 | - | -35.11 | - | Upgrade |
Long-Term Debt Repaid | - | -10.4 | -10.99 | -9.47 | -6.87 | -6.84 | Upgrade |
Total Debt Repaid | -207.76 | -207.96 | -144.49 | -9.47 | -41.98 | -6.84 | Upgrade |
Net Debt Issued (Repaid) | -92.37 | -207.96 | -144.49 | 135.14 | -41.98 | 41.33 | Upgrade |
Common Dividends Paid | -47.4 | -47.4 | - | - | - | - | Upgrade |
Other Financing Activities | -8.28 | -8.28 | - | - | -154.52 | -40.78 | Upgrade |
Financing Cash Flow | -148.05 | -263.63 | -144.49 | 135.14 | -196.5 | 0.55 | Upgrade |
Foreign Exchange Rate Adjustments | 4.15 | 6.69 | 0.36 | -0.08 | -0.66 | -0.54 | Upgrade |
Net Cash Flow | 27.12 | 32.45 | -2.21 | -5.16 | -69.55 | 63.54 | Upgrade |
Free Cash Flow | 146.31 | 282.77 | 145.98 | -117.45 | 65.59 | 116.75 | Upgrade |
Free Cash Flow Growth | -1.02% | 93.70% | - | - | -43.82% | 61.30% | Upgrade |
Free Cash Flow Margin | 2.95% | 5.89% | 3.35% | -2.80% | 1.85% | 3.62% | Upgrade |
Free Cash Flow Per Share | 7.39 | 14.29 | 7.38 | -5.93 | 3.31 | 5.90 | Upgrade |
Cash Interest Paid | 13.35 | 12.76 | 23.07 | 13.75 | 3.29 | 4.41 | Upgrade |
Cash Income Tax Paid | 47.52 | 12.13 | 48.01 | 90.85 | 43.9 | 35.78 | Upgrade |
Levered Free Cash Flow | 103.95 | 231.93 | 123.94 | -175.65 | -91.04 | 58.66 | Upgrade |
Unlevered Free Cash Flow | 111.91 | 238.35 | 138.58 | -167.41 | -89.26 | 61.1 | Upgrade |
Change in Net Working Capital | 75.04 | -71.65 | -79.65 | 274.04 | 262.09 | 82.47 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.